These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Pareek M, Pattison HM. Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968 [Abstract] [Full Text] [Related]
6. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW. Clin Infect Dis; 2006 Feb 01; 42(3):315-9. PubMed ID: 16392073 [Abstract] [Full Text] [Related]
7. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 Feb 01; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
11. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Mrozek-Budzyn D, Kiełtyka A, Majewska R. Pediatr Infect Dis J; 2010 May 01; 29(5):397-400. PubMed ID: 19952979 [Abstract] [Full Text] [Related]
12. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct 01; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related]
13. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument. Brown KF, Shanley R, Cowley NA, van Wijgerden J, Toff P, Falconer M, Ramsay M, Hudson MJ, Green J, Vincent CA, Kroll JS, Fraser G, Sevdalis N. Vaccine; 2011 Feb 11; 29(8):1700-9. PubMed ID: 21185850 [Abstract] [Full Text] [Related]
14. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
16. [Vaccinations in early infancy -- results of an epidemiological cross-sectional study in Hamburg]. Fell G, David C, Reintjes R. Gesundheitswesen; 2005 Jan 25; 67(1):27-32. PubMed ID: 15672303 [Abstract] [Full Text] [Related]
17. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 25; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related]
18. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pediatrics; 2006 Jul 25; 118(1):e139-50. PubMed ID: 16818529 [Abstract] [Full Text] [Related]
19. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL. J Microbiol Immunol Infect; 2005 Jun 25; 38(3):169-75. PubMed ID: 15986066 [Abstract] [Full Text] [Related]
20. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age. Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P. Vaccine; 2009 May 05; 27(20):2701-6. PubMed ID: 19428882 [Abstract] [Full Text] [Related] Page: [Next] [New Search]